Pharmacovigilance challenges in Biosimilars
Same proportion pharmacovigilance for biosimilars has comparatively more different from other products. Biosimilars 2019 session mainly look that have already been announced to include enhanced tracking and follow-up of post marketing surveillance issues, and on FDA initiative planned different changes in AERS, pilots of new developed post market strategies of drug-monitoring and ADR related problems. The guidelines of biosimilars for pharmacovigilance and pharma epidemiology are the points that shall be laid emphasis in the session In USA average annual income mostly spend on biologics comparing to generic drugs for example:16% on biologics and 3% on other drugs.
Related Conference of Pharmacovigilance challenges in Biosimilars
May 16-17, 2024
16th International Conference on Tissue Science and Regenerative Medicine
Rome, Italy
October 03-04, 2024
15th International Conference on Biofuels and Bioenergy
Singapore City, Singapore
Pharmacovigilance challenges in Biosimilars Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Regenerative Medicine Market - Tissue Science 2024 (Italy)
- .Bone Tissue Engineering - Tissue Science 2024 (Italy)
- Advances in analytical techniques - DRUG CHEMISTRY CONF 2024 (UK)
- Adverse drug reactions - DRUG CHEMISTRY CONF 2024 (UK)
- Anti-Aging, Regenerative and functional Medicine - Tissue Science 2024 (Italy)
- Applications of Tissue Engineering - Tissue Science 2024 (Italy)
- Artificial intelligence in drug discovery - DRUG CHEMISTRY CONF 2024 (UK)
- Artificial Organs - Tissue Science 2024 (Italy)
- Bio Banking - Tissue Science 2024 (Italy)
- Biofabrication and 3D Printing - Tissue Science 2024 (Italy)
- Biomaterials and Bioengineering - Tissue Science 2024 (Italy)
- Biomedical Engineering Techniques - Tissue Science 2024 (Italy)
- Biotechnology - BIOTECH ASIA PACIFIC 2024 (Spain)
- Biotechnology and nanotechnology in stem cells - Tissue Science 2024 (Italy)
- Cardiovascular Regeneration: - Tissue Science 2024 (Italy)
- Cell and Organ Regeneration - Tissue Science 2024 (Italy)
- Cellular and gene Therapies - Tissue Science 2024 (Italy)
- Challenges in translating research to practice - DRUG CHEMISTRY CONF 2024 (UK)
- Clinical Applications and Translational Research: - Tissue Science 2024 (Italy)
- Clinical trial design and compliance - DRUG CHEMISTRY CONF 2024 (UK)
- Dental and Craniofacial Regeneration: - Tissue Science 2024 (Italy)
- Drug pricing and affordability - DRUG CHEMISTRY CONF 2024 (UK)
- Emerging Technologies and Future Trends - Tissue Science 2024 (Italy)
- Ethical considerations in drug development - DRUG CHEMISTRY CONF 2024 (UK)
- Gene and Immunotherapy - Tissue Science 2024 (Italy)
- Global Perspectives and Healthcare Equity: - Tissue Science 2024 (Italy)
- Immunomodulation and Tissue Compatibility - Tissue Science 2024 (Italy)
- Medicinal chemistry approaches for specific diseases - DRUG CHEMISTRY CONF 2024 (UK)
- Musculoskeletal Regeneration: - Tissue Science 2024 (Italy)
- Nanotechnology in drug delivery - DRUG CHEMISTRY CONF 2024 (UK)
- Natural products in drug discovery - DRUG CHEMISTRY CONF 2024 (UK)
- Neuro regeneration and Brain Repair: - Tissue Science 2024 (Italy)
- Pharmaceutical Biotechnology - BIOTECH ASIA PACIFIC 2024 (Spain)
- Pharmaceutical Biotechnology - BIOTECH ASIA PACIFIC 2024 (Spain)
- Preclinical and clinical studies - DRUG CHEMISTRY CONF 2024 (UK)
- Rational drug design - DRUG CHEMISTRY CONF 2024 (UK)
- Regenerative Rehabilitation - Tissue Science 2024 (Italy)
- Soft Tissue Replacement - Tissue Science 2024 (Italy)
- Stem Cell Bioprocessing - Tissue Science 2024 (Italy)
- Stem Cell Treatments - Tissue Science 2024 (Italy)
- Stem Cells and Regenerative Therapies: - Tissue Science 2024 (Italy)
- test - DRUG CHEMISTRY CONF 2024 (UK)
- Tissue Engineering - Tissue Science 2024 (Italy)
- Tissue Engineering and Biomaterials - Tissue Science 2024 (Italy)
- Tissue Repair and Regeneration - Tissue Science 2024 (Italy)
- Workshops and Interactive Sessions: - Tissue Science 2024 (Italy)